.png)
The system also features the Aegis Detector System, engineered to enhance image clarity and low-contrast detectability while supporting low-dose imaging protocols
Women’s longevity is the top wellness trend of the year
The programme will focus on research-to-policy translation, implementation science, real-world evidence, community participation, research integrity and AI in health research
£375,000 Innovate UK-backed partnership to use data analytics and predictive modelling to improve formulation, product development and decision-making
Board approves Mexico and Canada subsidiaries as the company advances international expansion and integrates its Rs. 91 crore Apnar Pharma acquisition
The company currently holds 96% of Bharat Serums and Vaccines directly, while the remaining 4% is held through its wholly owned subsidiary, Appian Properties
Field data indicates that joint and body pain and other musculoskeletal conditions account for 22% of commonly observed conditions, followed by respiratory tract infections at 18% and common cold and flu at 15%
The company plans to use proceeds from the fresh issue primarily for repayment or pre-payment of borrowings, capital expenditure at its Hyderabad facilities
The company’s Sustainability Report 2025–26 highlights progress across ESG priorities
The results support advancing both programs as it seeks to develop therapies for major unmet needs in eye care.
Robenacoxib Injection is indicated for postoperative pain and inflammation associated with soft tissue surgery in dogs
The technology combines a novel fluorescent probe, TZ-48, with a smartphone-integrated system called ADxFluor
The company said it intends to challenge the order through the appropriate appellate process
According to company’s regulatory filing, the inspection was conducted from August 17 to August 25, 2026, and concluded with the issuance of a Form 483 containing seven observations
The initial portfolio comprises products across sterile injectables, biologics and topical formulations to be manufactured at Aurigene’s facilities in India
The investment further strengthens the company’s track record of partnering with high-quality mid-market businesses and providing tailored capital solutions
The rating agency independently prepared its ESG assessment using publicly available information relating to the company
The trial is intended to generate clinical evidence for PADN in a patient population where treatment options remain limited
The move to invest in Ampin C&I Power Twelve is expected to increase the use of renewable energy and potentially lower energy costs
The new framework with PHARMEXCIL is intended to strengthen collaboration between the regulator and the pharmaceutical export industry while supporting the government's broader Ease of Doing Business agenda
Subscribe To Our Newsletter & Stay Updated
